BELLOMO, GIOVANNI
 Distribuzione geografica
Continente #
AS - Asia 1.021
NA - Nord America 346
SA - Sud America 336
EU - Europa 240
Continente sconosciuto - Info sul continente non disponibili 56
AF - Africa 20
Totale 2.019
Nazione #
US - Stati Uniti d'America 301
BR - Brasile 276
HK - Hong Kong 228
SG - Singapore 216
BD - Bangladesh 178
VN - Vietnam 166
IT - Italia 141
CN - Cina 137
DE - Germania 54
KR - Corea 32
ID - Indonesia 22
AR - Argentina 19
CA - Canada 18
FR - Francia 18
MX - Messico 17
IN - India 16
EC - Ecuador 14
CO - Colombia 8
CL - Cile 6
PH - Filippine 5
KE - Kenya 4
PE - Perù 4
PL - Polonia 4
RU - Federazione Russa 4
UA - Ucraina 4
ZA - Sudafrica 4
AZ - Azerbaigian 3
JM - Giamaica 3
MA - Marocco 3
NL - Olanda 3
UY - Uruguay 3
VE - Venezuela 3
BE - Belgio 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
ES - Italia 2
ET - Etiopia 2
GB - Regno Unito 2
GT - Guatemala 2
HN - Honduras 2
IQ - Iraq 2
OM - Oman 2
PK - Pakistan 2
PY - Paraguay 2
SE - Svezia 2
TN - Tunisia 2
AT - Austria 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
GE - Georgia 1
IL - Israele 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PT - Portogallo 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 1.964
Città #
Hong Kong 228
Ho Chi Minh City 61
Ashburn 52
Frankfurt am Main 52
San Jose 40
Beijing 38
Hanoi 34
Singapore 34
Seoul 32
New York 30
Chicago 17
Los Angeles 17
Milan 16
Santa Clara 16
São Paulo 16
Rome 15
Buffalo 11
Naples 11
Dallas 9
Haiphong 9
Brasília 8
Mexico City 8
Guayaquil 7
Rio de Janeiro 7
Toronto 7
Palermo 6
Porto Alegre 6
Salvador 6
Campinas 5
Da Nang 5
Thái Bình 5
Belo Horizonte 4
Chennai 4
Council Bluffs 4
Duque de Caxias 4
Florence 4
Jundiaí 4
Manaus 4
Nairobi 4
Ninh Bình 4
Ribeirão Preto 4
Thái Nguyên 4
Bauru 3
Bengaluru 3
Bogotá 3
Bắc Ninh 3
Can Tho 3
Cincinnati 3
Curitiba 3
Genoa 3
Hải Dương 3
Jakarta 3
Las Vegas 3
Lima 3
Mauá 3
Miami 3
Orem 3
Pasadena 3
Piracicaba 3
Quito 3
Reston 3
Santo André 3
Seattle 3
Uberlândia 3
Varginha 3
Venice 3
Verona 3
Addis Ababa 2
Alvorada 2
Americana 2
Aracaju 2
Arlington 2
Baku 2
Belém 2
Biên Hòa 2
Brooklyn 2
Buenos Aires 2
Cabo Frio 2
Calgary 2
Cariacica 2
Colombo 2
Esmeraldas 2
Formosa 2
Fortaleza 2
Goiânia 2
Guarulhos 2
Hưng Yên 2
Indaiatuba 2
Itaquaquecetuba 2
Jacksonville 2
João Pessoa 2
Lehigh Acres 2
Long Beach 2
Maceió 2
Montevideo 2
Mumbai 2
Muscat 2
Newark 2
Osasco 2
Palhoça 2
Totale 993
Nome #
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum 202
Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: Disease staging by NF-L, p-tau181, and GFAP 88
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay 85
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts 78
Molecular and cellular determinants of L-Dopa-induced dyskinesia in Parkinson’s Disease 60
The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction 58
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders 56
Association of αS-SAA kinetics with clinical scores in the clinical spectrum of Parkinson's disease 52
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment 52
Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease 51
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: Relevance for α-synuclein measurement 50
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays 49
Diagnostic performance of plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non‐AD dementias: An international multi‐center study 46
Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid 45
The National Italian Guidelines on the diagnosis and treatment of children with pediatric ataxias 44
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward 44
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 41
Are we ready for detecting α-synuclein prone to aggregation in patients? The case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as diagnostic tools 41
An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity? 41
Influence of co-pathology on CSF and plasma synaptic markers SNAP25 and VAMP2 in Alzheimer’s disease and Parkinson’s disease 40
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regions 38
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders 37
Unlocking the full clinical potential of the α-synuclein seed amplification assay 34
Serum level changes of the synaptic marker beta-synuclein in Alzheimer’s disease continuum and other dementias 34
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers 33
A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias 32
Revisiting paramagnetic relaxation enhancements in slowly rotating systems: how long is the long range? 30
Dissecting the Interactions between Human Serum Albumin and α-Synuclein: New Insights on the Factors Influencing α-Synuclein Aggregation in Biological Fluids 29
MULTIFREQUENCY BIOIMPEDENTIOMETER 29
Aquaporin-4 as an early cerebrospinal fluid biomarker of Alzheimer’s disease 28
Parkinson's and Lewy body dementia CSF biomarkers 28
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease 28
Quantification of SPECT Concentric Ring Artifacts by Radiomics and Radial Features 27
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 27
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 27
Modulation of Aβ42 Aggregation Kinetics and Pathway by Low-Molecular-Weight Inhibitors 26
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 26
Aggregation kinetics of the Aβ1-40 peptide monitored by NMR 26
Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer’s disease biomarkers 26
The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis 25
Seed amplification assays for diagnosing synucleinopathies: The issue of influencing factors 25
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease 25
Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer's Disease 25
Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias 24
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview 23
Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics 23
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? 21
Cerebrospinal fluid α-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer's disease 20
Multivariate Curve Resolution for 2D Solid-State NMR spectra 17
Phosphorylated α-synuclein in CSF and plasma does not reflect synucleinopathy 3
Totale 2.019
Categoria #
all - tutte 9.139
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.139


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025313 0 0 0 0 1 3 7 4 1 245 42 10
2025/20261.642 88 31 246 344 132 33 34 87 92 125 261 169
2026/202764 57 7 0 0 0 0 0 0 0 0 0 0
Totale 2.019